Literature DB >> 27020463

C5b-9 deposits on endomysial capillaries in non-dermatomyositis cases.

Anne K Braczynski1, Patrick N Harter1, Pia S Zeiner1, Ulrich Drott1, Dominique-Suzanne Tews1, Corinna Preusse2, Cornelia Penski1, Maika Dunst1, Joachim Weis3, Werner Stenzel2, Michel Mittelbronn4.   

Abstract

Deposits of the terminal-membrane-attack-complex (MAC) C5b-9 on perfascicular endomysial capillaries are generally regarded as diagnostic hallmark of dermatomyositis (DM). Although the pathophysiology is not clear, C5b-9 deposits on capillaries seem to be associated with microinfarctions and vascular damage. Here, we report on a series of 19 patients presenting with C5b-9 accumulation on endomysial capillaries in the absence of features for DM. To decipher differences in the capillary C5b-9 accumulation pattern between DM and non-DM cases, we assessed the extent of endomysial capillary C5b-9 deposits related to capillary density and extent of myofiber necrosis by immunohistochemistry in 12 DM and 8 control patients. We found similar numbers of C5b-9-positive myofibers in both DM and non-DM C5b-9(+) cases. The distribution pattern differed as DM cases showed significantly more perifascicular capillary C5b-9 deposits as compared to non-DM cases, which presented stronger endomysial capillary C5b-9 deposits in a diffuse pattern. While total capillary density was not differing, DM patients displayed significantly more C5b-9(+) necrotic fibers as compared to non-DM C5b-9(+). In summary, endomysial capillary C5b-9 deposits are present in a variety of non-DM cases, however with differing distribution pattern. In conclusion, capillary C5b-9(+) deposits should be assessed critically, taking into consideration the distribution pattern.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C5b-9; Dermatomyositis; MHC-I; Microvascular unit; Muscle disease

Mesh:

Substances:

Year:  2016        PMID: 27020463     DOI: 10.1016/j.nmd.2016.02.014

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  4 in total

Review 1.  Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.

Authors:  Renske G Kamperman; Anneke J van der Kooi; Marianne de Visser; Eleonora Aronica; Joost Raaphorst
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

2.  Diffuse microvascular C5b-9 deposition is a common feature in muscle and nerve biopsies from diabetic patients.

Authors:  Paul C Yell; Dennis K Burns; Evan G Dittmar; Charles L White; Chunyu Cai
Journal:  Acta Neuropathol Commun       Date:  2018-02-20       Impact factor: 7.801

3.  C1-inhibitor Deficiency Induces Myositis-like Symptoms Via the Deposition of the Membrane Attack Complex in the Muscle.

Authors:  Goichi Beck; Rika Yamashita; Chizu Saeki; Takuya Ogawa; Mikito Shimizu; Hideki Mochizuki
Journal:  Intern Med       Date:  2020-05-26       Impact factor: 1.271

4.  NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients.

Authors:  Corinna Preusse; Pascale Eede; Lucie Heinzeling; Kiara Freitag; Randi Koll; Waltraud Froehlich; Udo Schneider; Yves Allenbach; Olivier Benveniste; Anne Schänzer; Hans-Hilmar Goebel; Werner Stenzel; Josefine Radke
Journal:  Brain Pathol       Date:  2021-05       Impact factor: 6.508

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.